Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,310.00
Bid: 1,308.00
Ask: 1,314.00
Change: 10.00 (0.77%)
Spread: 6.00 (0.459%)
Open: 1,298.00
High: 1,314.00
Low: 1,298.00
Prev. Close: 1,300.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Sep 2020 07:00

RNS Number : 2792Y
Gamma Communications PLC
08 September 2020
 

8 September 2020

Gamma Communications plc

 

Non-Executive Director Appointments

 

Gamma Communications plc ("Gamma" or "the Group"), a leading, technology based provider of communications services to the business market in Western Europe announces the appointment of Xavier Robert and Charlotta Ginman as Non-Executive Directors of the Company with immediate effect.

 

Xavier has been a private equity professional for more than 20 years. He leads the investment activities of global private equity firm Bridgepoint in the UK and sits on its Executive and Investment Committees. He holds a strong expertise in TMT and notably chairs Calypso, a leading global capital market software provider, and Qualitest, the global market leading pure-play software testing company.

 

Charlotta qualified as a Chartered Accountant before spending a career in investment banking and commercial organisations, principally in technology-related businesses. She began her career at Ernst & Young in 1989, and was then appointed to a series of senior roles in investment banking with UBS, Deutsche Bank and JP Morgan both in London and Singapore.

 

Charlotta has also held senior roles within Nokia Corporation, including acting as Chief Financial Officer of its luxury mobile phone division Vertu Corporation Limited. Charlotta is an experienced NED, currently sitting on the Boards of Pacific Assets Trust plc, Polar Capital Technology Trust plc, Unicorn AIM VCT plc and Keywords Studios plc.

 

Richard Last, Chairman of Gamma, said:

 

"I'm very pleased to welcome Xavier and Charlotta to the Board. Charlotta has extensive technology sector experience from multinational incumbents such as Nokia and fast growth software and service providers like Keywords Studios. As an executive and NED she has supported the growth and development of businesses in the sector and will provide valuable insight as Gamma continues to execute its strategy.

 

 

Xavier's experience in identifying, acquiring, integrating and growing technology businesses is highly relevant to Gamma's international acquisition strategy. As we grow our footprint in both existing and new jurisdictions across Western Europe we look forward to his insight complementing the experience already on the Board."

 

 

Enquiries:

 

Gamma Communications plc Tel: +44 (0)333 006 5972

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

 

Investec Bank plc (NOMAD & Broker) Tel: +44 (0)207 597 5970

Virginia Bull

Patrick Robb

 

Tulchan Communications LLP (PR Adviser) Tel: +44 (0)207 353 4200

James Macey White

Matt Low

 

 

Additional Information:

Disclosures under Schedule 2 of the AIM Rules:

 

The following additional information relating to Mr Robert is disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Mr Xavier Jean Robert, aged 49, holds or has held the following directorships and/or partnerships in the previous five years:

 

Current directorships/partnerships

Past Directorships/partnerships

CALYPSO GROUP LUX SCA

CALYPSO GROUP UK LIMITED

QUANTUM HOLDING TOPCO LIMITED

SCI NOAILLES

 

 

BRIDGEPOINT ADVISERS II LIMITED

BRIDGEPOINT ADVISERS HOLDINGS

BRIDGEPOINT SP. Z O.O.

COMPAGNIE DU PONANT HOLDING

CALYPSO FX USD LIMITED

CALYPSO FX EUR LIMITED

CALYPSO GROUP US, INC

CALYPSO MERGER CO.

CALYPSO UK MIDCO LIMITED

CALYPSO UK TOPCO LIMITED

EFRONT HOLDING SAS

EFRONT MANCO

MAPIL TOPCO LIMITED

QUANTUM HOLDCO BIDCO INC

QUANTUM HOLDING FINCO LIMITED

QUANTUM HOLDING MIDCO 1 LIMITED

QUANTUM HOLDING MIDCO 2 LIMITED

QUANTUM HOLDING UK BIDCO LIMITED

 

Mr Robert was a director of Groupe Moniteur when it was subject to a scheme of arrangement and sold to a competitor post the global financial crisis.

 

No additional information relating to Mr Robert is required to be disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

 

 

The following additional information relating to Ms Ginman is disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Ms Maria Charlotta Ginman FCA, aged 55, holds or has held the following directorships and/or partnerships in the previous five years:

 

Current directorships/partnerships

Past Directorships/partnerships

Keywords Studios plc

Polar Capital Technology Trust plc

Pacific Assets Trust plc

Unicorn AIM VCT plc

The Queen's Club Limited

QC Holdings Limited

QC Ground Limited

 

Consort Medical PLC

Motif Bio plc

Kromek plc

Motif BioSciences, Inc

 

 

Ms Ginman' has also been known by the following surnames: Ginman-Horrell (current married name) and Ginman-Jones (former married name).

 

No additional information relating to Ms Ginman is required to be disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUMUBUPUGBM
Date   Source Headline
26th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 202411:09 amRNSHolding(s) in Company
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20241:57 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20243:19 pmRNSPublication of Notice of AGM
12th Apr 20243:05 pmRNSDirector/PDMR Shareholding
12th Apr 20243:00 pmRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20249:36 amRNSTransaction in Own Shares
3rd Apr 20247:55 amRNSTransaction in Own Shares
2nd Apr 20246:00 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:02 amRNSShare buyback programme
25th Mar 20247:01 amRNSFinal Results
25th Mar 20247:00 amRNSBoard Change and Committee Composition
22nd Mar 20245:20 pmRNSHolding(s) in Company
14th Mar 20247:30 amRNSDirector/PDMR Shareholding
1st Mar 20242:31 pmRNSTotal Voting Rights
14th Feb 20248:38 amRNSDirector/PDMR Shareholding
13th Feb 20248:00 amRNSSite visit for investors
1st Feb 20241:49 pmRNSTotal Voting Rights
17th Jan 20243:51 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSScheduled Trading Update
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights
28th Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20235:34 pmRNSHolding(s) in Company
21st Dec 20235:33 pmRNSHolding(s) in Company
13th Dec 20235:35 pmRNSDirector/PDMR Shareholding
13th Dec 202312:34 pmRNSIssue of Equity
5th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20234:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.